Don't invest unless you’re prepared to lose all the money you invest. This is a high-risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more.
Estimated reading time: 2 min
Due to the potential for losses, the Financial Conduct Authority (FCA) considers this investment to be high risk.
What are the key risks?
- You could lose all the money you invest
- If the business you invest in fails, you are likely to lose 100% of the money you invested. Most start-up businesses fail.
- You are unlikely to be protected if something goes wrong
- Protection from the Financial Services Compensation Scheme (FSCS), in relation to claims against failed regulated firms, does not cover poor investment performance. Try the FSCS investment protection checker here.
- Protection from the Financial Ombudsman Service (FOS) does not cover poor investment performance. If you have a complaint against an FCA-regulated firm, FOS may be able to consider it. Learn more about FOS protection here.
- You won’t get your money back quickly
- Even if the business you invest in is successful, it may take several years to get your money back. You are unlikely to be able to sell your investment early.
- The most likely way to get your money back is if the business is bought by another business or lists its shares on an exchange such as the London Stock Exchange. These events are not common.
- If you are investing in a start-up business, you should not expect to get your money back through dividends. Start-up businesses rarely pay these.
- Don’t put all your eggs in one basket
- Putting all your money into a single business or type of investment for example, is risky. Spreading your money across different investments makes you less dependent on any one to do well.
- A good rule of thumb is not to invest more than 10% of your money in high-risk investments.
- The value of your investment can be reduced
- The percentage of the business that you own will decrease if the business issues more shares. This could mean that the value of your investment reduces, depending on how much the business grows. Most start-up businesses issue multiple rounds of shares.
- These new shares could have additional rights that your shares don’t have, such as the right to receive a fixed dividend, which could further reduce your chances of getting a return on your investment.
If you are interested in learning more about how to protect yourself, visit the FCA’s website here.
| Type: | EIS |
|---|---|
| Sector: | Technology |
| Target return: | 4x |
| Funds raised / sought: | £400k / £1m |
| Minimum investment: | £19,950 |
| Next application deadline: | 31 Oct 2025 for first close |
Important documents
| Type: | EIS |
|---|---|
| Sector: | Technology |
| Target return: | 4x |
| Funds raised / sought: | £400k / £1m |
| Minimum investment: | £19,950 |
| Next application deadline: | 31 Oct 2025 for first close |
Important documents
| About this deal | What to expect post-investment |
|---|---|
| This is a co-investment alongside EHE Ventures, which has reviewed the opportunity. Please read the offer documents carefully. | EHE Ventures will produce initial and ongoing shareholder documents. |
This overview is provided to make it easier for you to form your own view about the opportunity.
Backed by Mars Petcare: £1.1 million ARR, all-in-one petcare subscription platform
For its size, the UK punches above its weight as a nation of pet-lovers. It’s the third-largest market for pet food in the world, after the US and China, in a global pet care market worth $346 billion.
UK pet owners each spend around £1,500 a year on pet health, spending a total of £225 million on supplements alone.
The market is reactive and fragmented. Owners have to juggle vets, insurance, food, and supplements, costing time and money and potentially resulting in preventable illnesses.
Scooch Pet Limited (“Scooch” or “the Company”) was set up in 2021 to help address this through its all-in-one platform for personalised pet care.
The platform combines vet-formulated, human-grade, plant-based supplements with an AI-powered app offering a virtual check-up, AI insights, reports and guidance as well as embedded insurance and 24/7 vet support. All this is available under a single subscription designed to identify, prevent and treat dog health issues, removing hassle from pet care.
The idea for Scooch came about during lockdown when exited entrepreneur Baris Ozaydinli’s puppy Rio experienced health issues. Baris decided to turn his 26 years’ experience in human wellness tech to create a personalised healthcare platform for pets, starting with dogs.
The Company reports promising traction. It has over 3,000 subscribers, and generated £1.1 million annual recurring revenue (ARR) in the year to December 2024 – an annual growth of 180%. It expects to be EBITDA positive by Q3 2026, not guaranteed. It was named AI Startup of the Year (UK & London) in 2024 and Top 10 Most Exciting New Startup UK by TechRound in 2025.
Since launch in 2021, Scooch was incubated by startup studio Founders Factory and has raised £2.2 million from leading investors including sector specialists Mars Petcare and Michelson Found Animals, as well as specialist AI tech fund EHE Ventures.
To fund the next stage of growth, Scooch is now seeking to raise £1 million under EIS. £400k has already been committed by EHE Ventures, which is leading the round, and Wealth Club has an initial £500k allocation – the minimum investment is £19,950 and you can apply online.
The round is being offered at £5.70 per share, equating to a pre-money value of approximately £9 million.
EHE Ventures believes the investment could potentially deliver a return in the region of 4x before EIS tax relief but after fees in five years – high risk and not guaranteed.
Please carefully read all investment documents prepared by the Company and EHE Ventures to form your own view.
Important: The information on this website is for experienced investors. It is not advice nor a research or personal recommendation to invest. If you’re unsure, please seek advice. Investments are for the long term. They are high risk and illiquid and can fall as well as rise in value, so you could get back less than you invest.
The deal at a glance
| Type | Single-company EIS private offer |
| Current round | £1m round |
| Notable current and previous investors | Mars Petcare, Founders Factory, R/GA Ventures, EHE Ventures, Michelson Found Animals |
| Fully diluted pre-money valuation | c.£9 million |
| Business / revenue model | D2C subscription with 60-85% gross margin |
| Revenue last full financial year | £1.1 million ARR |
Note: the Company is currently loss-making. Capital is at risk: you could lose your investment.
How does Scooch’s one-stop personalised healthcare platform aim to take the guesswork out of petcare?
Scooch helps pet owners diagnose, treat and prevent most common dog health issues without the need for visiting the vet.
The Company operates on a Subscription Direct to Consumer (D2C) model, selling through its own website, as well through distribution platforms such as Amazon and TikTok Shop.
Pet owners sign up for a tiered subscription, which provides health-tracking and online assessments, 24/7 video-vet support, as well as free pet insurance for accidents and injuries. The Company uses the data it collects to make personalised recommendations from its range of proprietary formulated and vet approved supplements, dog food and treatments for most common dog health problems (from Allergy & Itching, Anal Glands, Joints & Mobility to Calming, Digestive Issues and Dental care). Scooch reports it can save pet owners £12.1 million per year just for anal glands and allergy-related vet bills.
About Scooch: From Founder and CEO Baris Ozaydinli
We greatly value Scooch's unique approach to providing pet parents with the opportunity to better understand their pet's health and how to improve it.
Risks – important
This is a single company offer with no diversification. It involves investing in an early-stage, loss-making business, which is by nature high risk and prone to failure. There is a risk that the capital raised may not be sufficient to achieve the Company’s objectives. You could lose all the amount you invest.
Like all investments available through Wealth Club, it is only for experienced investors happy to make their own investment decisions without advice.
There is no ready market for unlisted EIS shares: they are illiquid and hard to sell and value. There will need to be an exit for you to receive a realised return on your investment. Exits are likely to take considerably longer than the three-year minimum EIS holding period; equally, an exit within three years could impact tax relief.
To claim tax relief, you will need an EIS3 certificate, normally issued once shares have been allotted. This can take several months: please check the deployment timescales carefully. Tax reliefs depend on company maintaining its EIS-qualifying status. Remember, tax rules can change and benefits depend on circumstances. Before you invest, please carefully read the Information Memorandum which contains further details on the considerable risks – alongside the Wealth Club Risks and Commitments.
Private offer structure and fees
Investors will invest directly in Scooch Pet Limited. Shares issued in this round are expected to be EIS-qualifying – not guaranteed.
Investors pay no direct initial or ongoing charges to invest. Fundraising costs are being met by the Company. Wealth Club will be entitled to a performance fee on exit.
Wealth Club investors will invest using a nominee structure. This service is provided by Wealth Club’s subsidiary companies Wealth Club Asset Management Limited (authorised and regulated by the FCA) and Wealth Club Nominees Limited. Wealth Club Nominees Ltd will be completing the share subscription documentation on investors’ behalf.
Please refer to the Schedule of Charges for more details on charges (may vary for different rounds).
All the services Wealth Club and, where applicable, its subsidiaries provide are governed by the Terms and Conditions of the Wealth Club Services.
About the co-investor, EHE Ventures
EHE Ventures is a Manchester-based venture investor backing early-stage AI-driven startups across the UK. EHE aims to support its portfolio companies with capital as well as hands-on operational and technical support to help founders validate ideas, build scalable products, and accelerate growth.
EHE launched its AI Growth Fund in October 2024 and has since invested £1.3 million in 7 EIS and SEIS companies.
This financial promotion has been communicated and approved by Wealth Club Ltd on 15 October 2025
Wealth Club aims to make it easier for experienced investors to find information on – and apply for – investments. You should base your investment decision on the offer documents and ensure you have read and fully understand them before investing. The information on this webpage is a marketing communication. It is not advice or a personal or research recommendation to buy any of the investments mentioned, nor does it include any opinion as to the present or future value or price of these investments. It does not satisfy legal requirements promoting investment research independence and is thus not subject to prohibitions on dealing ahead of its dissemination.